3
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Neuroma, Acoustic
3
Surgical Wound Infection
2
Stomatitis
2
Nasopharyngeal Carcinoma
2
Breast Neoplasms
2
Sepsis
1
Neutropenia
1
Neoplasms
1
Nasopharyngeal Neoplasms
1
Colonic Neoplasms
1
Interventions
Filgrastim
7
pegylated granulocyte colony-stimulating factor
5
pegfilgrastim
5
Cytarabine
4
Ciprofloxacin
4
Cefepime
4
Vancomycin
3
Leucovorin
3
Fluorouracil
3
Amikacin
3
trifluridine tipiracil drug combination
2
Piperacillin, Tazobactam Drug Combination
2
Methylprednisolone
2
Meropenem
2
Irinotecan
2
Etoposide
2
Daptomycin
2
Cisplatin
2
Ceftazidime
2
ziprasidone
1
trilaciclib
1
sargramostim
1
niraparib
1
liposomal amphotericin B
1
lintuzumab
1
leridistim
1
isavuconazole
1
fludarabine phosphate
1
flt3 ligand protein
1
fish oil triglycerides
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Neutropenia
×
Gentamicins
×
Clear all
NCT01931592
2017-05-08
CLEAR
University of Cologne
Phase 2/3
Terminated
29 enrolled